- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05745831
Development and Validation of a Therapeutic Decision Aid in Ectopic Pregnancy: GEUDECID Study (GEUDECID)
Development and Validation of a Therapeutic Decision Aid in Less Active Ectopic Pregnancy
Study Overview
Status
Intervention / Treatment
Detailed Description
In less active ectopic pregnancy, two treatments are possible: a medical treatment using methotrexate or a surgical management.
A discret choice experiment study was performed to reveal women's preferences between these two options. In conclusion, calculated preferences are 47.5 and 52.5%, revealing a difficult choice for women. This study also lead to identify the main attributes important to make the choice. We were then able to create a therapeutic decision aid to help this shared decision.
This aid needs to be validated, following steps for validation. This study is the last step in women in situation of less active ectopic pregnancy.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Women who speak and read french
- Not opposed to participate to the research
- With a tubal ectopic pregnancy visible at sonography
- with an HCG rate under 10 000UI/ml
Exclusion Criteria:
- Cardiac activity present in the embryo
- Hemoperitoin
- Hemodynamic instability
- Spontaneous pelvic pain
- Contre indication to methotrexate
- Protected adult patient
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Women with a less active ectopic pregnancy using a therapeutic decision tool for treatment decision
Women will have a therapeutic decision tool to help medical decision making and women and doctors will have to fill a questionnaire about the tool and the decision made
|
A therapeutic decision tool will be used and its usefulness, comprehension and satisfaction will be evaluated
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Validate acceptability of the therapeutic decision tool in women managed for less active ectopic tubal pregnancy.
Time Frame: One day
|
Acceptability will be evaluated using a score from the Traditional Decisional Conflict Scale (DCS) translated in french.
Women will fill it after the choice of the treatment and the realisation of it.
|
One day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Validate acceptability of the therapeutic decision tool in doctors who managed women for less active ectopic tubal pregnancy.
Time Frame: One day
|
The same Traditional Decisional Conflict Scale (DCS) will be used in gynecologist who will managed the women
|
One day
|
To evaluate satisfaction of women and of doctor in using the tool
Time Frame: One day
|
A specific questionnaire using Likert scale will be used
|
One day
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- C22-51
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on To Validate a Decision Aid for Ectopic Pregnancy
-
Nan ShenNovartisNot yet recruitingCharacterize the Molecular Profile of Lupus Nephritis(LN) Patients to Understand Themechanism(s)Contributing to Patient Responsiveness to Soc | Integrated Analysis of LN Patient Molecular Profiling and Clinical Annotations to Understand LNdisease Heterogeneity for Disease Endotype | Validate the Association of the Candidate Biomarker Panel Proposed in Table 3-1 With LN Diseasemonitoring
Clinical Trials on Therapeutic decision tool
-
Hadassah Medical OrganizationRecruitingSedentary Behavior | Risk ReductionIsrael
-
Maastricht UniversityNot yet recruitingLung Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | NSCLC Stage IV
-
Duke UniversityNational Cancer Institute (NCI)CompletedDuctal Carcinoma in SituUnited States
-
VA Office of Research and DevelopmentRecruitingTotal Knee ArthroplastyUnited States
-
University of MichiganNational Institute of Nursing Research (NINR)Completed
-
Hospital Universitario ArabaInstituto de Salud Carlos III; Ibermática/i3B; BiorabaCompletedObstructive Sleep Apnea (OSA)Spain
-
University of California, San FranciscoNational Comprehensive Cancer NetworkCompletedNon-small Cell Lung CancerUnited States
-
Saint Luke's Health SystemMerck Sharp & Dohme LLCRecruiting
-
University of MichiganEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedDisability PhysicalUnited States
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Preventive Services and Health Promotion Research NetworkCompletedHypercholesterolemia | Cardiovascular RiskSpain